Early real-world implant experience with a helix-fixation ventricular leadless pacemaker

Devi G. Nair, Derek V. Exner, Vivek Y. Reddy, Nima Badie, David Ligon, Marc A. Miller, Bridget Lee, Brandon Doty, Athanasios Thomaides, Zayd Eldadah, Malick Islam, Cyrus Hadadi

Research output: Contribution to journalArticlepeer-review


Background: Roughly one in six patients receiving conventional transvenous pacemaker systems experience significant complications within 1 year of implant, mainly due to the transvenous lead and subcutaneous pocket. A new helix-fixation single-chamber ventricular leadless pacemaker (LP) system capable of pre-deployment exploratory electrical mapping is commercially available. Such an LP may mitigate complications while streamlining the implantation. In this study, the initial real-world implant experience of the helix-fixation LP was evaluated following its commercial release. Methods: In patients indicated for single-chamber right ventricular pacing, helix-fixation Aveir VR LPs (Abbott, Abbott Park, IL) were implanted using the dedicated loading tool, introducer, and delivery catheter. Implant procedural characteristics, electrical parameters, and any 30-day procedure-related adverse events of consecutive implant attempts were retrospectively evaluated. Results: A total of 167 patients with Class I indication for permanent pacing received implants in four North American centers (57% male, 70 years old). Pre-fixation electrical mapping of potential sites allowed repositioning to be avoided in 95.7% of patients. Median [interquartile range] LP procedure and fluoroscopy durations were 25.5 min [20.0, 35.0] and 5.7 min [4.0, 9.2], respectively. Pacing capture threshold, sensed R-wave amplitude, and impedance were 0.8 V [0.5, 1.3], 9.0 mV [6.0, 12.0], and 705 Ω [550, 910], respectively. Implantation was successful in 98.8% of patients, with 98.2% free from acute adverse events. Conclusions: The initial, real-world experience of the helix-fixation ventricular leadless pacemaker demonstrated safe and efficient implantation with minimal repositioning, viable electrical metrics, and limited acute complications. Graphical abstract: Helix-fixation single-chamber ventricular leadless pacemakers were implanted in 167 patients, with a median procedure time of 25.5 minutes, 98.8% implant success, and 98.2% freedom from acute adverse events. (Figure presented.).

Original languageEnglish
JournalJournal of Interventional Cardiac Electrophysiology
StateAccepted/In press - 2024


  • Aveir
  • Helix fixation
  • Implant procedure
  • Leadless pacemaker
  • Pacemaker complications
  • Single-chamber pacemaker


Dive into the research topics of 'Early real-world implant experience with a helix-fixation ventricular leadless pacemaker'. Together they form a unique fingerprint.

Cite this